Literature DB >> 24273633

Synthesis and Cytotoxicity of Semisynthetic Withalongolide A Analogues.

Hashim F Motiwala1, Joseph Bazzill, Abbas Samadi, Huaping Zhang, Barbara N Timmermann, Mark S Cohen, Jeffrey Aubé.   

Abstract

The natural product withaferin A exhibits potent antitumor activity and other diverse pharmacological activities. The recently discovered withalongolide A, a C-19 hydroxylated congener of withaferin A, was recently reported to possess cytotoxic activity against head and neck squamous cell carcinomas. Semisynthetic acetylated analogues of withalongolide A were shown to be considerably more cytotoxic than the parent compound. To further explore the structure-activity relationships, 20 new semisynthetic analogues of withalongolide A were synthesized and evaluated for cytotoxic activity against four different cancer cell lines. A number of derivatives were found to be more potent than the parent compound and withaferin A.

Entities:  

Keywords:  DRO81-1; Withalongolide A; jaborosalactone; macrocycle; triacetate; withaferin A

Year:  2013        PMID: 24273633      PMCID: PMC3835334          DOI: 10.1021/ml400267q

Source DB:  PubMed          Journal:  ACS Med Chem Lett        ISSN: 1948-5875            Impact factor:   4.345


  21 in total

Review 1.  Withanolides and related ergostane-type steroids.

Authors:  E Glotter
Journal:  Nat Prod Rep       Date:  1991-08       Impact factor: 13.423

2.  Antiproliferative activity of withanolides against human breast cancer cell lines.

Authors:  Rubén P Machin; Adriana S Veleiro; Viviana E Nicotra; Juan C Oberti; José M Padrón
Journal:  J Nat Prod       Date:  2010-05-28       Impact factor: 4.050

Review 3.  Natural withanolides: an overview.

Authors:  Li-Xia Chen; Hao He; Feng Qiu
Journal:  Nat Prod Rep       Date:  2011-02-23       Impact factor: 13.423

4.  Thermodynamic and Structural Effects of Macrocyclization as a Constraining Method in Protein-Ligand Interactions.

Authors:  John E Delorbe; John H Clements; Benjamin B Whiddon; Stephen F Martin
Journal:  ACS Med Chem Lett       Date:  2010-11-11       Impact factor: 4.345

5.  Structure-activity relationship studies of discodermolide and its semisynthetic acetylated analogs on microtubule function and cytotoxicity.

Authors:  R A Isbrucker; S P Gunasekera; R E Longley
Journal:  Cancer Chemother Pharmacol       Date:  2001-07       Impact factor: 3.333

Review 6.  Resveratrol and derivatives for the prevention and treatment of cancer.

Authors:  Simone Fulda
Journal:  Drug Discov Today       Date:  2010-08-06       Impact factor: 7.851

7.  Cytotoxic withanolide constituents of Physalis longifolia.

Authors:  Huaping Zhang; Abbas K Samadi; Robert J Gallagher; Juan J Araya; Xiaoqin Tong; Victor W Day; Mark S Cohen; Kelly Kindscher; Rao Gollapudi; Barbara N Timmermann
Journal:  J Nat Prod       Date:  2011-11-18       Impact factor: 4.050

8.  The tumor proteasome is a primary target for the natural anticancer compound Withaferin A isolated from "Indian winter cherry".

Authors:  Huanjie Yang; Guoqing Shi; Q Ping Dou
Journal:  Mol Pharmacol       Date:  2006-11-08       Impact factor: 4.436

9.  Barrier protective effects of withaferin A in HMGB1-induced inflammatory responses in both cellular and animal models.

Authors:  Wonhwa Lee; Tae Hoon Kim; Sae-Kwang Ku; Kyoung-Jin Min; Hyun-Shik Lee; Taeg Kyu Kwon; Jong-Sup Bae
Journal:  Toxicol Appl Pharmacol       Date:  2012-04-27       Impact factor: 4.219

10.  A novel MMP-2 inhibitor 3-azidowithaferin A (3-azidoWA) abrogates cancer cell invasion and angiogenesis by modulating extracellular Par-4.

Authors:  Bilal Rah; Hina Amin; Khalid Yousuf; Sheema Khan; Gayatri Jamwal; Debaraj Mukherjee; Anindya Goswami
Journal:  PLoS One       Date:  2012-09-04       Impact factor: 3.240

View more
  7 in total

1.  Chemistry of withaferin-A: chemo, regio, and stereoselective synthesis of novel spiro-pyrrolizidino-oxindole adducts of withaferin-A via one-pot three-component [3+2] azomethine ylide cycloaddition and their cytotoxicity evaluation.

Authors:  Yogesh P Bharitkar; Satish Kanhar; Neradibilli Suneel; Susanta Kumar Mondal; Abhijit Hazra; Nirup B Mondal
Journal:  Mol Divers       Date:  2015-03-08       Impact factor: 2.943

2.  Computational studies evidenced the potential of steroidal lactone to disrupt surface interaction of SARS-CoV-2 spike protein and hACE2.

Authors:  Ajay Yadav; Monu Dinesh Ojha; P Hariprasad
Journal:  Comput Biol Med       Date:  2022-05-13       Impact factor: 6.698

Review 3.  Antiproliferative withanolides from several solanaceous species.

Authors:  Huaping Zhang; Cong-Mei Cao; Robert J Gallagher; Barbara N Timmermann
Journal:  Nat Prod Res       Date:  2014-05-28       Impact factor: 2.861

4.  Novel HSP90 inhibitors effectively target functions of thyroid cancer stem cell preventing migration and invasion.

Authors:  Peter T White; Chitra Subramanian; Qing Zhu; Huaping Zhang; Huiping Zhao; Robert Gallagher; Barbara N Timmermann; Brian S J Blagg; Mark S Cohen
Journal:  Surgery       Date:  2015-11-02       Impact factor: 3.982

Review 5.  Withania Somnifera (Ashwagandha) and Withaferin A: Potential in Integrative Oncology.

Authors:  Rinku Dutta; Roukiah Khalil; Ryan Green; Shyam S Mohapatra; Subhra Mohapatra
Journal:  Int J Mol Sci       Date:  2019-10-25       Impact factor: 5.923

Review 6.  Recent Advances in the Chemistry and Therapeutic Evaluation of Naturally Occurring and Synthetic Withanolides.

Authors:  Amandeep Singh; Asif Raza; Shantu Amin; Chendil Damodaran; Arun K Sharma
Journal:  Molecules       Date:  2022-01-28       Impact factor: 4.411

Review 7.  Natural Withanolides in the Treatment of Chronic Diseases.

Authors:  Peter T White; Chitra Subramanian; Hashim F Motiwala; Mark S Cohen
Journal:  Adv Exp Med Biol       Date:  2016       Impact factor: 2.622

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.